ベータ
治験レーダーAI
フィルター基準に一致する試験が1件見つかりました
タイル表示

Preservation of Beta-cell Function in Type 2 Diabetes Mellitus 58

完了
治験(臨床試験)の詳細は主に英語で提供されていますが、治験レーダーAIがサポートします!「治験解説」をクリックして、選択した言語で試験情報を表示し、議論してください。
治験番号 NCT00232583 は 介入研究 臨床試験 で、2型糖尿病 を対象とした研究でした。現在は 完了 です。2003年11月1日 に開始し、58 名の参加者 が参加しました。この試験は テキサス大学南西部医学センター によって主導され、2011年12月1日 に完了しました。ClinicalTrials.gov からの最新更新日は 2017年12月14日 です。
概要
The study evaluates the rate beta-cell function decline in newly diagnosed type 2 diabetic patients on two different treatment regimens: insulin and metformin versus glyburide, metformin and pioglitazone.
詳細説明
This is a 72 months long randomized clinical trial longitudinally evaluating beta-cell function, as well as glycemic control and inflammatory markers in newly diagnosed type 2 diabetic patients on two different treatment regimens: insulin and metformin versus glyburide, metformin and pioglitazone.
公式タイトル

Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

疾患名
2型糖尿病
刊行物
この臨床試験について発表された科学記事と研究論文:
その他の研究識別子
  • 1003-623
NCT番号
開始日
2003-11
最終更新日
2017-12-14
終了予定日
2011-12
目標参加者数
58
試験の種類
介入研究
治験の相・段階
該当なし
状況
完了
キーワード
TYpe 2 diabetes mellitus
Newly diagnosed
Beta-cell function
主目的
治療
割付方法
無作為化
介入モデル
並行割当
盲検化
なし(非盲検)
群(アーム)/介入
参加グループ/群介入/治療法
実薬対照薬Metfomin and Insulin
Metformin 1000mg/BID and Insulin Novolog 70/30 per protocol titration
メトホルミン
Metformin 1000mg/BID
インスリン
Insulin Novolg 70/30 per protocol titration
実薬対照薬Metformin, Pioglitazone and Glyburide
Metformin 1000mg/BID, Pioglitazone 45 mg and glyburide per protocol titration
Metfomin
Metformin 1000mg/BID
Pioglitazone
Pioglitazone 45mg
glyburide
Glyburide per protocol titration
主要評価項目
評価指標指標の説明時間枠
Beta-cell Function - C-peptide AUC (Area Under the Curve)
C-peptide AUC during a 3-hours mixed meal challenge testing
72 months
副次評価項目
評価指標指標の説明時間枠
Insulin Sensitivity as Measure be Matsuda Index
C-peptide-based Matsuda index using following formula: Matsuda index = 500,00 / root square \[(fasting c-peptide x fasting glucose x 333) x (average c-peptide 0-120 mins x average glucose 0-120 mins x 333). Higher the Matsuda index, better the insulin sensitivity.
72 months
Bet-cell Function Measured by Disposition Index
Disposition index was measured by multiplying the insulin secretion (C-peptide AUC/C-peptide AUC glucose) by the Matsuda index. Disposition index reflects the beta-cell function adjusted for total body insulin sensitivity
72 months
Weight
Body Weight
72 months
Inflammatory Markers - hsCRP
Inflammatory markers - hsCRP (C reactive protein)
72 months
Inflammatory Markers -Fibrinogen
Inflammatory markers - Fibrinogen
72 months
Inflammatory Markers - PAI-1
Inflammatory markers - PAI-1 (Plasminogen activator inhibitor type 1)
72 months
Quality of Life Survey (QoL) - Current Health Perception
Current health perception was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a Likert scale score of 1-5, where 1 = much better than 3 months ago; 2 - Somewhat better now than 3 months ago; 3 - About the same; 4 - Somewhat worse now than 3 months ago; 5 Much worse now than 3 months ago.
72 months
Quality of Life Survey (QoL) - Treatment Satisfaction
Treatment satisfaction was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a Likert scale score of 1-5, where 1 - very satisfied; 2 - moderately satisfied; 3 - neither satisfied nor dissatisfied; 4 - moderately dissatisfied; 5 - very dissatisfied.
72 months
Quality of Life Survey (QoL) - Treatment Impact
Treatment impact was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a Likert scale score of 1-5, where 1 - very satisfied; 2 - moderately satisfied; 3 - neither satisfied nor dissatisfied; 4 - moderately dissatisfied; 5 - very dissatisfied.
72 months
Quality of Life Survey (QoL) - Social or Vocational Worry
Social or vocational worry was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a Likert scale score of 0-5, where 0 - does not apply; 1 - never; 2 - seldom; 3 - sometimes; 4 - often; 5 - all of the time.
72 months
Quality of Life Survey (QoL) - Hypoglycemia Fear
Hypoglycemia fear was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a Likert scale score of 1-5, where 1 - never worry; 2 - rarely water; 3 - sometimes worry; 4 - often worry; 5 - very often worry
72 months
Quality of Life Survey (QoL) - Glycemia Control Perception
Glycemia control perception was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a scale score of 1-7, where 1 - extremely controlled and 7 - not at all controlled.
72 months
Quality of Life Survey (QoL) - Lifestyle Flexibility
Lifestyle flexibility was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a Likert scale score of 1 to 5, where 1 - a great deal of choice; 2 - a lot of choice; 3 - some choice; 4 - a little choice; 5 - no choice.
72 months
Quality of Life Survey (QoL) - Social Stigma
Social stigma was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a Likert scale score of 1 to 5, where 1- strongly agree; 2 - somewhat agree; 3 - neither agree nor disagree; 4 - somewhat disagree; 5 - strongly disagree.
72 months
Quality of Life Survey (QoL) - Satisfaction With Insulin Treatment
Satisfaction with insulin treatment was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a scale score of 1 to 7, where 1 extremely satisfied to 7 - not at all satisfied.
72 months
Quality of Life Survey (QoL) - Willingness to Continue Insulin Treatment
Willingness to continue insulin treatment was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a scale score of 1 to 7, where 1 extremely willing to 7 - not at all willing.
72 months
適格基準

対象年齢
成人, 高齢者
試験の最低年齢
25 Years
対象性別
全て
  • type 2 diabetes mellitus diagnosed within the prior 2 months
  • HbA1c > 7% at the time of inclusion
  • willing to perform intensive diabetes management
  • able to comply with treatment and follow-up regimen

  • HbA1c > 8% at time of randomization
  • creatinine > 1.5 mg/dl
  • liver function tests > 3 times the upper limit of normal
  • severe anemia
  • severe proliferative retinopathy
  • NYHA class III or IV heart failure
  • active CAD or recent (within 6 months) MI
  • pregnant, willing to get pregnant, or not willing to practice any contraceptive method
  • non-english speaking
  • active heavy alcohol or illicit drug users (within past 6 months)
  • history of lactic acidosis
University of Texas Southwestern Medical Center logoテキサス大学南西部医学センター284 件のアクティブな治験を探索
責任者
Ildiko Lingvay, 主任研究者, MD, MPH, MSCS, University of Texas Southwestern Medical Center
連絡先情報がありません。
1 1カ国の場所

Texas

University of Texas Southwestern, Dallas, Texas, 75390, United States